Robin Huff is the global regulatory strategy lead at Quintiles, where she helps develop regulatory strategies for customers’ clinical programs taking place around the world. Dr. Huff is a renowned regulatory expert with 18 years of experience in the pharmaceutical and biologics industry.
Before joining Quintiles, she spent seven years at the U.S. Food and Drug Administration, first a regulatory reviewer and then a supervisory reviewer. Dr. Huff also served as senior director of regulatory affairs at Grifols Therapeutics, and its predecessor Talecris Biotherapeutics, where she built regulatory strategies to support clinical development projects and major manufacturing changes.
Dr. Huff earned her bachelor’s degree in biochemistry from Virginia Polytechnic Institute and State University and her Ph.D. in pharmacology from Duke University.